Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vlad Popovici

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|May 6, 2024
An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancerEva Budinská, Martina Čarnogurská, Tina Catela Ivković, et al.
Human Genetics|December 22, 2009
Examination of FGFRL1 as a candidate gene for diaphragmatic defects at chromosome 4p16.3 shows that Fgfrl1 null mice have reduced expression of Tpm3, sarcomere genes and Lrtm1 in the diaphragmNelson LopezJimenez, Simon Gerber, Vlad Popovici, et al.
Cancer Medicine|April 30, 2025
Search for Mutations Connected With Non-Response to Anti-EGFR Therapy in mCRC in the Morphologically Defined Regions of Primary TumoursMartina Čarnogurská, Valeriia Serhiivna Vasylieva, Táňa Macháčková, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancerVlad Popovici, Eva Budinska, Sabine Tejpar, et al.
BMC Cancer|February 11, 2010
Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissueJanine Antonov, Vlad Popovici, Mauro Delorenzi, et al.
The Journal of Pathology|July 10, 2013
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancerEva Budinska, Vlad Popovici, Sabine Tejpar, et al.
The Journal of Pathology|August 29, 2012
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequencySun Tian, Paul Roepman, Vlad Popovici, et al.
Cancers|October 13, 2021
Colorectal Tumour Mucosa Microbiome Is Enriched in Oral Pathogens and Defines Three Subtypes That Correlate with Markers of Tumour ProgressionBarbora Zwinsová, Vyacheslav A Petrov, Martina Hrivňáková, et al.
Journal of the National Cancer Institute|September 24, 2014
Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression dataAntonio F Di Narzo, Sabine Tejpar, Simona Rossi, et al.
Elife|November 13, 2023
Molecular portraits of colorectal cancer morphological regionsEva Budinská, Martina Hrivňáková, Tina Catela Ivkovic, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|May 6, 2024
An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancerEva Budinská, Martina Čarnogurská, Tina Catela Ivković, et al.
Human Genetics|December 22, 2009
Examination of FGFRL1 as a candidate gene for diaphragmatic defects at chromosome 4p16.3 shows that Fgfrl1 null mice have reduced expression of Tpm3, sarcomere genes and Lrtm1 in the diaphragmNelson LopezJimenez, Simon Gerber, Vlad Popovici, et al.
Cancer Medicine|April 30, 2025
Search for Mutations Connected With Non-Response to Anti-EGFR Therapy in mCRC in the Morphologically Defined Regions of Primary TumoursMartina Čarnogurská, Valeriia Serhiivna Vasylieva, Táňa Macháčková, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancerVlad Popovici, Eva Budinska, Sabine Tejpar, et al.
BMC Cancer|February 11, 2010
Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissueJanine Antonov, Vlad Popovici, Mauro Delorenzi, et al.
The Journal of Pathology|July 10, 2013
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancerEva Budinska, Vlad Popovici, Sabine Tejpar, et al.
The Journal of Pathology|August 29, 2012
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequencySun Tian, Paul Roepman, Vlad Popovici, et al.
Cancers|October 13, 2021
Colorectal Tumour Mucosa Microbiome Is Enriched in Oral Pathogens and Defines Three Subtypes That Correlate with Markers of Tumour ProgressionBarbora Zwinsová, Vyacheslav A Petrov, Martina Hrivňáková, et al.
Journal of the National Cancer Institute|September 24, 2014
Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression dataAntonio F Di Narzo, Sabine Tejpar, Simona Rossi, et al.
Elife|November 13, 2023
Molecular portraits of colorectal cancer morphological regionsEva Budinská, Martina Hrivňáková, Tina Catela Ivkovic, et al.
Pageof 4